Biodegradable 3D Injectable Amino Acid Hydrogels Delivering Immune Adjuvant for Enhancing Immunotherapy in Colon Cancer
Cancer Science · 2025
DOI: 10.1111/cas.70156 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, 2025. Verfasst von Mengfei Yin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Affiliated Tumor Hospital of Nantong University, Nantong, China. Hauptthemen laut MEDLINE: Hydrogels, Colonic Neoplasms, Immunotherapy, Adjuvants, Immunologic. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Nantong Health Commission Project, the Science and Technology R&D Foundation of Nantong City.
Abstract (Originalsprache)
Cancer immunotherapy using toll‐like receptor agonists (R837) has been extensively investigated and demonstrates potential as an effective adjuvant. Due to the potential for severe side effects associated with R837, the subcutaneous injection of a hydrogel scaffold may enhance its efficacy. Herein, we propose a biodegradable 3D injectable scaffold as an injectable delivery carrier for R837 (R837@Gel), to control the release rate of R837 and be friendly to subcutaneous tissue. Biodegradable 3D injectable amino acid hydrogels were constructed by catalase effect during Fmoc‐Phe and Phe 2 substrates. After subcutaneous injection, R837@Gel formed a hydrogel‐like component, provided adequate 3D support, and released R837 in order owing to the decomposition of amino acids. Effective CD4 + and CD8 + T‐cell responses were observed, promoted by R837@Gel ( p < 0.001). The amino acid hydrogel scaffold exhibited a favorable safety profile and could be degraded successfully. The biodegradable 3D injectable amino acid hydrogels prolonged the action duration of R837 and markedly enhanced the efficacy of PD‐1. The 3D amino acid hydrogel scaffold encapsulating R837 in combination with immune checkpoint blockade represents a potent strategy for enhancing antitumor immunotherapy while mitigating systemic toxicity concerns. Moreover, controlled drug administration via subdermal implants has significant potential for reducing the compliance burden associated with frequent dosing. The combination of biocompatibility, ease of modification, and the ability to create a 3D microenvironment makes amino acid hydrogels a valuable tool in the field of regenerative medicine and tissue engineering.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Affiliated Tumor Hospital of Nantong University, Nantong, China.
- The People's Hospital of Danyang, Affiliated Danyang Hospital of Nantong University, Danyang, China.
- Institute for Applied Research in Public Health, School of Public Health, Nantong University, Nantong, China.
ORCID-Profile: Li Song, Donglin Xia
Förderung
- Nantong Health Commission Project
- the Science and Technology R&D Foundation of Nantong City
Zitieren
APA
Yin, M., Mao, L., Zhang, X., Ji, J., Song, L., Ma, Q., Xia, D., & Yang, L. (2025). Biodegradable 3D Injectable Amino Acid Hydrogels Delivering Immune Adjuvant for Enhancing Immunotherapy in Colon Cancer. Cancer Science. https://doi.org/10.1111/cas.70156
Vancouver
Yin M, Mao L, Zhang X, Ji J, Song L, Ma Q, et al. Biodegradable 3D Injectable Amino Acid Hydrogels Delivering Immune Adjuvant for Enhancing Immunotherapy in Colon Cancer. Cancer Science. 2025. doi:10.1111/cas.70156
BibTeX
@article{Yin2025,
author = {Yin, Mengfei and Mao, Ling and Zhang, Xunlei and Ji, Jiali and Song, Li and Ma, Qingxia and Xia, Donglin and Yang, Lei},
title = {Biodegradable 3D Injectable Amino Acid Hydrogels Delivering Immune Adjuvant for Enhancing Immunotherapy in Colon Cancer},
journal = {Cancer Science},
year = {2025},
doi = {10.1111/cas.70156}
}
EUVIMED